View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Dostarlimab 500, Tumor Biomarker Defined, Cycle 1-4
Protocol-ID: 2632 V1.0 (Mini), DOST500, Tumor Biomarker Defined, C1-4Indication(s)
- Tumor Biomarker Defined (Mismatch Repair - deficient / Microsatellite Instability - high (dMMR/MSI-H), POLE-altered)
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 07.06.2024